Category: Uncategorized

AIBILI-Association for Innovation and Biomedical Research on Light and Image recently give an interview to Exame Informática program of SIC Notícias about the EVICR.net Eye Platform.

The EVICR.net Eye Platform is a long-term initiative to collect longitudinal anonymised clinical data and eye images from the network’s centers across Europe. The data platform is available for analysis by all EVICR.net partners to develop a better understanding of the progression of eye diseases and new ways to improve patient care and prevent vision loss.

Please check the extract of the program in this link
https://lnkd.in/dE6jKfCe

Boehringer Ingelheim is funding the EVICR.net Eye Platform and a pilot study that is collecting and will analyze data in patients with intermediate AMD or early atrophic AMD.

AIBILI is proud to perform a study on the effectiveness of educational materials available for Vabysmo®, Eylea® and Lucentis®.

The MARVEL Study, supported by INFARMED, I.P., is conducted by the Coimbra Regional Pharmacovigilance Unit of AIBILI and aims to evaluate the effectiveness of educational materials for healthcare professionals and the target general population, as additional measures of risk minimization for the drugs Vabysmo® (faricimab), Eylea® (aflibercept) and Lucentis® (ranibizumab).

More information: https://www.infarmed.pt/web/infarmed/infarmed/-/journal_content/56/15786/9521902

Presentations:

• Abnormal retinal fluid in eyes with diabetic center-involved macular edema

Prof. José Cunha-Vaz

 

• A Conversion Model for OCTA Vessel Density Metrics in Diabetic Eyes: Angiovue vs Cirrus Angioplex

Doutora Ana Rita Santos

 

• Statins and genetics in the risk of progression of age-related macular degeneration – The Coimbra Eye Study

Dra. Patrícia Barreto

 

• Combination of Ultra-widefield Colour Fundus Photography and Optical Coherence Tomography Angiography identify different subtypes of non-proliferative diabetic retinopathy

Dra. Ana Almeida

 

Posters:

• CLARUS (or Wide-Field Fundus Imaging) Improves ETDRS Grading with Classic 7-fields Fundus Photographs

Dra. Marta Lopes

 

Audio narrated free paper:

• Statin intake time and risk for progression of age-related macular degeneration – a comparison of two Cox regression models applied to the Coimbra Eye Study

Doutora Rita Coimbra

AIBILI will be presenting at EVOLVE – Digital Transformation Summit 2023 the EVICR.net Eye Platform. This summit will be organised by APDC on October 11, 2023, in Lisbon, Portugal. The EVICR.net Eye Platform is a long-term initiative to collect longitudinal anonymised clinical data and eye images from the network’s centers across Europe. The data platform will be available for analysis by all EVICR.net partners to develop a better understanding of the progression of eye diseases and new ways to improve patient care and prevent vision loss.
Boehringer Ingelheim is funding the EVICR.net Eye Platform and a pilot study that is collecting and will analyze data in patients with intermediate AMD or early atrophic AMD.
Learn more at: https://www.evicr.net/eyeplatform/

AIBILI was present at this ERA4Health workshop – Analysis of bottlenecks and challenges in designing and conducting investigator-initiated multinational clinical studies – through Dr. Cecília Martinho and Dr. Joana Tavares, which took place in Paris, France, on 15-16/09/2023. Challenges in designing and conducting investigator-initiated multinational clinical studies were discussed.

‘À Mesa com Saúde’ is a health literacy initiative organized by Faculty of Medicine of the Coimbra University and iCBR – Coimbra Institute for Clinical and Biomedical Research, in partnership with the Coimbra School of Tourism and the Coimbra University Hospital, which consists of organizing dinners commented by chefs, scientists and clinicians, which aim to address diseases and their prevention through diet. The dinner on May 5th has Vision Sciences as its theme and has the participation of Dr. Patricia Barreto from AIBILI.

AIBILI, as Coordinating Centre of EVICR.net, is organizing the EVICR.net 18th Members Meeting on October 19-20, 2023, in Milan, Italy.

AIBILI will be organising the EAsDEC congress 2023 on June 1-3, 2023 in Coimbra Portugal.

Do not miss the opportunity to joint a forum of ophthalmologists and diabetologists aimed at increasing the understanding of diabetic retinopathy, its development, diagnosis and treatment.

For more information and registration please visit: https://www.easdec.org/pages/default.asp?id=2

AIBILI has been recognised as an EATRIS Expert Centre covering areas as regulatory strategy and execution and health technology assessment.

EATRIS put out a call for an expression of interest from institutions to provide EATRIS decentralised expert services. Seven applied and were ratified by the EATRIS Boards. The Centres cover a wide range of areas, such as innovation management, regulatory strategy and execution, and health technology assessment.

AIBILI 2022 report is now available!

Please check it here.